4FW-17669-91366
2 vaccinations
8 coded responses
23 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 370 / TN
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
- 2021-01-06
-
2021-01-07
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Site: Pain · ChillsFree text: But it's very cold outside- cannot attribute strictly to vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-08
- 2021-01-09
-
2021-01-10
Survey response — days 1–6 daily, dose 1MedDRA: Injection site induration, Reaction to previous exposure to any vaccine — Feeling: Good · Site: ItchingFree text: A “hard†spot remains where the injection occurred. This is something I experience with my flu sit as wellMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-11
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Injection site induration, Injection site nodule — Feeling: Good · Site: Pain, ItchingFree text: Still have a knot - hard spot where shot was administeredMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Survey response — day 7, dose 1MedDRA: Injection site nodule, Injection site pain — Feeling: GoodFree text: Knot at injection site not as big still hurts when pushedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
-
2021-01-27
Dose 2 — Pfizer-BioNTech
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Injection site induration — Feeling: Good · Site: Redness, ItchingFree text: Injection site is hard to touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Injection site induration, Injection site mass — Feeling: Good · Site: Pain, Redness, ItchingFree text: Knot at injection site still present has not grown in size since yesterday and remains hard to the touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Injection site nodule — Feeling: Good · Site: ItchingFree text: Knot at injection site has decreased in sizeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-12
- 2021-04-28
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Pre-existing disease — Feeling: FairFree text: Allergy/asthma related heat index in 90/100s this weekMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-01-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): But it's very cold outside- cannot attribute strictly to vaccine
Systemic reaction (other): A “hard†spot remains where the injection occurred. This is something I experience with my flu sit as well
Systemic reaction (other): Still have a knot - hard spot where shot was administered
Release 1 — day 7, dose 1
Systemic reaction (other): Knot at injection site not as big still hurts when pushed
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Injection site is hard to touch
Systemic reaction (other): Knot at injection site still present has not grown in size since yesterday and remains hard to the touch
Systemic reaction (other): Knot at injection site has decreased in size
Release 9 — 6 months, dose 2
Symptoms: Allergy/asthma related heat index in 90/100s this week
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-existing disease | ✓ | · | ✓ |
| SRO | Injection site induration | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
| SRO | Injection site nodule | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Reaction to previous exposure to any vaccine | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release